Fractyl Health, Inc. (GUTS) income statement
GUTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$1.08+0.11 (+11.87%)
Close on Nov 18, 2026Market cap $171.91MP/E –Yield –
Fractyl Health, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -744.2%
Financial strength
- Current ratio
- 3.15
- Debt to equity
- -18.29
- Debt to assets
- 37.1%
- Cash to current liabilities
- 299.6%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?